Phase 1/2a, open‐label, multicenter study of <scp>RM</scp>‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinomaDavid M. Cognetti, Ann M. Gillenwater, D. McDonald et al.|Head & Neck|2021Cited by 170